Matching trials
2,411 results
- PREPAREIndependent statistical analysis of PRevention Using EPA Against coloREctal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04216251).
- Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract: Complete Statistical AnalysisIndependent statistical analysis of Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PREVACIndependent statistical analysis of PREVAC (NCT02876328), a randomized phase 2 Ebola vaccination trial evaluating antibody response through Month 12 using a stratified Cochran-Mantel-Haenszel analysis.
- PREVAILIndependent statistical analysis of A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection: primary endpoint results,…
- PREVENTIndependent statistical analysis of Prazosin to Prevent COVID-19 (PREVENT-COVID Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04365257).
- Preventing and Arresting Dental Root Surface Caries in Community-dwelling Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Preventing and Arresting Dental Root Surface Caries in Community-dwelling Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preventing Sickle Cell Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sickle Cell Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02373241).
- Prevention of Acute Kidney Injury in Cardiac Surgery Patients: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Acute Kidney Injury in Cardiac Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00921518).
- Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Bone Loss After Acute SCI by Zoledronic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02325414).
- Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02074631).
- Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Prevention of GBS Colonization Via Immunity: Complete Statistical AnalysisIndependent statistical analysis of Prevention of GBS Colonization Via Immunity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00128219).
- Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00381615).
- PRIDE-HTIndependent statistical analysis of PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00203502).
- PRIMCABIndependent statistical analysis of Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide: primary endpoint results,…
- PRO 140 in Treatment-Experienced HIV-1 Subjects: Complete Statistical AnalysisIndependent statistical analysis of PRO 140 in Treatment-Experienced HIV-1 Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03902522).
- PRO-148Independent statistical analysis of Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PRODIGE 18Independent statistical analysis of PRODIGE 18, a randomized phase 2 trial evaluating chemotherapy associated with either cetuximab or bevacizumab in KRAS wild-type metastatic colorectal cancer after progression following first-line bevacizumab.
- PRODIGE 22-ECKINOXEAn independent statistical analysis of PRODIGE 22-ECKINOXE, a randomized phase 2 trial of perioperative chemotherapy strategies in locally advanced colon cancer, focusing on histological tumor response and the statistical methods appropriate for…
- PRODIGE 44Independent statistical analysis of PRODIGE 44, a randomized phase 2 trial evaluating neoadjuvant mFolfirinox with or without preoperative concomitant chemoradiotherapy in borderline resectable pancreatic carcinoma, with emphasis on the R0 resection margin…
- ProFEIBAIndependent statistical analysis of Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PROGIndependent statistical analysis of Progesterone Treatment for Cocaine-dependent Women: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00632099).
- Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers: Complete Statistical AnalysisIndependent statistical analysis of Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PROLONG-ANG3Independent statistical analysis of A Study of LY3561774 in Participants With Mixed Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05256654).
- Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients: Complete Statistical AnalysisIndependent statistical analysis of Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PROMISEIndependent statistical analysis of Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis: Complete Statistical AnalysisIndependent statistical analysis of Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Prophylactic Ivermectin in COVID-19 Contacts: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Ivermectin in COVID-19 Contacts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04422561).
- Propranolol for Challenging Behaviors in Autism: Complete Statistical AnalysisIndependent statistical analysis of Propranolol for Challenging Behaviors in Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04047355).
- PROSEEK: A Phase 2 Study In Early Parkinson’s Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706: Complete Statistical AnalysisIndependent statistical analysis of PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706: primary endpoint results, effect estimate with…
- Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy: Complete Statistical AnalysisIndependent statistical analysis of Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Prospective Randomized Double Blind Clinical Trial of Polyhexamethylene Biguanide Impregnated Foam Dressing: Complete Statistical AnalysisIndependent statistical analysis of Prospective Randomized Double Blind Clinical Trial of Polyhexamethylene Biguanide Impregnated Foam Dressing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting: Complete Statistical AnalysisIndependent statistical analysis of Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Protocol for Women at Increased Risk of Developing Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Protocol for Women at Increased Risk of Developing Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00291135).
- Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01288235).
- PSMA PreRPIndependent statistical analysis of Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919111).
- PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176497).
- Psoriatic Arthritis Study of Izokibep: Complete Statistical AnalysisIndependent statistical analysis of Psoriatic Arthritis Study of Izokibep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05623345).
- Psychopharmacology for Cocaine Dependence – Buspirone: Complete Statistical AnalysisIndependent statistical analysis of Psychopharmacology for Cocaine Dependence - Buspirone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01267292).
- PTCLIndependent statistical analysis of Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00865969).
- PULSARIndependent statistical analysis of A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03408483).
- Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients: Complete Statistical AnalysisIndependent statistical analysis of Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: Complete Statistical AnalysisIndependent statistical analysis of Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC): Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…